PHAS

PhaseBio Pharmaceuticals, Inc. Common Stock

Delisted

PHAS was delisted on the 2nd of November, 2022.

5 hedge funds and large institutions have $15.6K invested in PhaseBio Pharmaceuticals, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 34 closing their positions.

Holders
5
Holders Change
-33
Holders Change %
-86.84%
% of All Funds
0.08%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
Closed
34
Calls
Puts
Net Calls
Net Calls Change